Latest news

Having worked in and alongside histopathology departments for several years, I’ve seen the incredible dedication of teams under relentless pressure. I’ve sat with service leads staring down weeks of case backlogs, watched departments scramble to fill persistent vacancies, and listened to the quiet frustration when traditional outsourcing models didn’t quite meet the need. Pathology is the backbone of so much of modern medicine, yet it often runs in the background, essential but under-resourced, quietly absorbing ever-increasing demand.

Beyond the 50-year-old locum tenens model lies a digital pathology revolution where Diagnexia connects practices to global subspecialty experts through AI-enhanced workflows, ensuring faster diagnoses and substantial cost savings while improving quality and service metrics

In this episode, Deciphex CEO Donal O’Shea featured on AI Ireland's podcast to share his journey from academia to entrepreneurship, and how he’s leading the charge in transforming global pathology services with AI.

Diagnexia, a leader in digital pathology services, proudly announces the launch of its Global Education and Outreach Program, a transformative initiative aimed at enhancing education, diagnostic access and healthcare outcomes in regions with limited pathology resources.

Charles River Laboratories International, Inc. (NYSE: CRL) and Deciphex, a leader in AI-powered digital pathology, today announced the next phase of a strategic collaboration to focus on advancing cutting-edge image management solutions

Deciphex, the research pathology division of Deciphex, proudly announces the launch of Diagnexia Analytix, a comprehensive pathology service offering that integrates advanced analytics and AI-powered workflows with expert-led diagnostics to elevate study outcomes.

Deciphex, a leader in AI-powered digital pathology, has closed its Series C financing, raising €31 million to address the acute global pathology crisis.

United Kingdom – Diagnexia UK Limited is delighted to announce its recent accreditation to ISO 15189:2022

Diagnexia, the clinical digital pathology service of Deciphex, proudly announces the opening of a new, cutting-edge histopathology laboratory in Oxford.

Deciphex today announced the launch of VICT3R, a groundbreaking initiative aimed at transforming nonclinical drug and chemical safety evaluation

Diagnexia has successfully met the rigorous standards set by the College of American Pathologists (CAP).

Deciphex announces that it is the first DICOM-native platform to fully facilitate the archival and reconstruction of regulated digital studies.

Diagnexia, the digital pathology diagnostics leader and a division of Deciphex, today unveiled its strategic relocation to a larger facility within Exeter Science Park.

Collaboration Agreement Seeks to engage AI to Transform Non-clinical Pathology Assessments in Drug Discovery and Development

Powered by digital pathology and AI algorithms, Patholytix Foresight drives speed and quality in toxicologic pathology practices

Diagnexia, a leader in pathology expertise, is thrilled to announce a significant collaborative agreement with Aga Khan University Hospital (AKUH), Nairobi.

In 2023, a Toxicological Pathologist at Integrated Biologix GmbH, Sarah Taplin, became the first consultant pathologist to perform a regulated digital peer review for a study conducted at a drug development research provider.

Deciphex, an innovator in Pathology AI, announces the strategic appointment of Dr. Pierre Moulin as Chief Scientific Officer.

Deciphex is delighted to announce its recognition at the Irish Medtech Awards 2023.

Deciphex, a trailblazer in digital pathology solutions, is delighted to announce a successful €10m venture debt financing round.

Deciphex, a pioneering leader in digital pathology solutions, is pleased to announce the acceptance of, Diagnexia UK Limited, into the Medicines and Healthcare products Regulatory Agency (MHRA) GLP Monitoring Programme as a prospective member, and the expected achievement of Good Laboratory Practice (GLP) compliance statement for its cutting-edge facility located in Exeter.

The Toronto Diagnexia Accessioning Office is Now Open

The company has seen a 450% increase in demand for services since December. The expansion is expected to create numerous employment opportunities in the Exeter region, further stimulating the local economy.

The company is seeing a ten fold increase in demand quarterly and this strategic investment will allow them to grow their capacity, increase headcount, further improve services and expand to new markets.

Reduces Time and Cost of Safety Assessment Studies

Diagnexia is the first fully digital, subspecialty led, remote diagnostic & consult service.

Deciphex have announced today that they are first in industry to offer clients Good Laboratory Practice (GLP) compliant digital primary review.

Investment will fuel Deciphex’s role in using AI to accelerate pathology diagnostics, improving productivity and patient outcomes.

Deciphex have introduced a new service to facilitate on-demand sharing of studies with any veterinary consultant pathologist on a pay-per-use basis with zero cost to the consultant.

Diagnexia, a new generation of technology-enabled care provider, powered by Deciphex’s core technologies, announces that they have secured CQC (Care Quality Commission) certification.